Trials / Completed
CompletedNCT00992277
In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2)
In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2) Intended for Treatment of Soft Tissue
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Syneron Medical · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will: Evaluate the in vivo histological and molecular effects of treatment with eMatrixCO2 and to determine the dynamics of their development over time following treatment. Determine the safety and efficacy of treatment with eMatrixCO2 for use in Aesthetic dermatological procedures requiring the ablation, vaporization, excision, incision, or coagulation of soft tissue.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Ablation and skin resurfacing |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-04-01
- First posted
- 2009-10-09
- Last updated
- 2014-12-02
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00992277. Inclusion in this directory is not an endorsement.